Roche investor conference call on the acquisition of InterMune

Monday, 25 August

Conference call to discuss the announcement that Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc. (NASDAQ: ITMN) have entered into a definitive merger agreement for Roche to fully acquire InterMune.

The conference call has ended.